Levetiracetam Tablet
Product Images NDC 50405-302

11 FDA label images from Sohm, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50405-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sohm, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (1027d3d1 0448 499c A075 62f4377f532e 01)

Description (1027d3d1 0448 499c A075 62f4377f532e 01)
Chemical structure diagram of Levetiracetam, showing the molecular arrangement including a pyrrolidone ring, ethyl side chain, and amide functional group.*
FDA Label Image

Figure 01 (1027d3d1 0448 499c A075 62f4377f532e 02)

Figure 01 (1027d3d1 0448 499c A075 62f4377f532e 02)
Bar chart comparing the percentage of patients among three groups: Placebo, Levetiracetam Tablet 1000 mg/day, and Levetiracetam Tablet 3000 mg/day. The chart shows increasing patient percentages with higher Levetiracetam doses, with statistically significant differences indicated versus placebo.*
FDA Label Image

Figure 02 (1027d3d1 0448 499c A075 62f4377f532e 03)

Figure 02 (1027d3d1 0448 499c A075 62f4377f532e 03)
A bar chart showing the percentage of patients responding to Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The chart depicts higher response rates in Levetiracetam groups compared to placebo, with statistically significant differences marked by asterisks.*
FDA Label Image

Figure 03 (1027d3d1 0448 499c A075 62f4377f532e 04)

Figure 03 (1027d3d1 0448 499c A075 62f4377f532e 04)
A bar graph comparing the percentage of patients between two groups: Placebo (N=104) with 14.4%, and Levetiracetam 3000 mg/day (N=130) with 39.4%. The graph highlights a statistically significant difference between Levetiracetam and placebo.*
FDA Label Image

Figure 04 (1027d3d1 0448 499c A075 62f4377f532e 05)

Figure 04 (1027d3d1 0448 499c A075 62f4377f532e 05)
Bar chart comparing the percentage of patients between placebo and Levetiracetam Tablet groups. The graph shows approximately 19.6% for placebo (N=97) and 44.6% for Levetiracetam Tablet (N=101), indicating a statistically significant difference versus placebo.*
FDA Label Image

Figure 05 (1027d3d1 0448 499c A075 62f4377f532e 06)

Figure 05 (1027d3d1 0448 499c A075 62f4377f532e 06)
A bar graph comparing the percentage of patients between placebo (19.6%) and Levetiracetam (43.1%) groups, indicating a statistically significant difference favoring Levetiracetam in the measured outcome.*
FDA Label Image

Figure 06 (1027d3d1 0448 499c A075 62f4377f532e 07)

Figure 06 (1027d3d1 0448 499c A075 62f4377f532e 07)
A bar graph comparing the percentage of patients responding to Placebo and Levetiracetam treatment. The vertical axis shows percentage of patients, with placebo at 45.2% and Levetiracetam at 72.2%. The graph notes statistical significance for Levetiracetam versus placebo.*
FDA Label Image

Levetiracetam-tablets-label-250-mg-120s (Levetiracetam Tablets Label 250 mg 120s)

Levetiracetam-tablets-label-250-mg-120s (Levetiracetam Tablets Label 250 mg 120s)
Levetiracetam Tablets USP 250 mg tablet packaging label showing NDC 50405-300-02. The label states the product contains 250 mg Levetiracetam per tablet, with a package of 120 tablets, distributed by SOHM, Inc. and manufactured by Stallion Laboratories Pvt. Ltd. The label includes storage instructions, child-resistant warnings, and a barcode.*
FDA Label Image

Levetiracetam-tablets-label-500-mg-120s (Levetiracetam Tablets Label 500 mg 120s)

Levetiracetam-tablets-label-500-mg-120s (Levetiracetam Tablets Label 500 mg 120s)
Levetiracetam Tablets, USP 500 mg oral tablets label showing a 120-tablet package. The label includes storage instructions, pharmacist dispensing guidance, and manufacturer information for SOHM, Inc. and Stallion Laboratories Pvt. Ltd. It also displays the NDC number 50405-301-02 and advises dispensing the medication guide separately to each patient.*
FDA Label Image

Levetiracetam-tablets-label-750-mg-120s (Levetiracetam Tablets Label 750 mg 120s)

Levetiracetam-tablets-label-750-mg-120s (Levetiracetam Tablets Label 750 mg 120s)
Levetiracetam Tablets, USP 750 mg oral tablets label by SOHM, Inc. The label shows 120 tablets per container with instructions for pharmacist, dosage, storage, child-resistant packaging, and manufacturing information from Stallion Laboratories Pvt. Ltd., India. Includes NDC 50405-302-02 and a barcode.*
FDA Label Image

Levetiracetam-tablets-label-1000-mg-60s (Levetiracetam Tablets Label 1000 mg 60s)

Levetiracetam-tablets-label-1000-mg-60s (Levetiracetam Tablets Label 1000 mg 60s)
Levetiracetam Tablets, USP 1000 mg oral tablets packaging label. The label shows 60 tablets per container and notes the product is distributed by SOHM, Inc and manufactured by Stallion Laboratories Pvt. Ltd. The label includes storage instructions, child-resistant packaging warning, and a printed medication guide URL. Batch coding and expiration placeholders are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.